Abstract
In the field of radiation oncology, equipments for fractionated stereotactic radiotherapy and single-dose radiosurgery have become increasingly accurate. Out of brain lesions, extracranial stereotactic treatments are more and more frequently considered. New imaging techniques (spect MRI, PET) provide further relevant information to slice images (CT-Scan, MRI). However, the treatment of extracranial lesions needs to take into account organ mobility (tumor and healthy tissue) whilst retaining the ability of stereotactically locating the target. Real time tracking systems allow to keep high conformality to moving and deforming targets. Currently, the most significant developments are in the field of extracranial stereotactic radiotherapy in lung, liver and prostate cancers, together with re-irradiation and oligo metastases. Recent data will be presented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
